-
Sep 29, 2025NHP-Based Pharmacology And Pharmacodynamic Services | Prisys BiotechPrisys Biotech offers cutting-edge non-human primate (NHP) pharmacology and pharmacodynamic services. Our advanced disease models, translational platforms, and AAALAC-accredited... -
Jul 30, 2025Top COPD Research Models & Respiratory Platform Excellence By PrisysNHP COPD animal models and integrated respiratory research platform—empowering drug discovery through non-human primate models and precise drug delivery systems. -
Jul 22, 2025NHP Acute Hemorrhage Model: A Crucial Tool For Accelerating Novel Hematology ...Explore how Prisys Biotech's non-human primate (NHP) acute hemorrhage model provides a high-fidelity platform for evaluating novel therapies like hemoglobin-based oxygen carrier... -
Jul 18, 2025Pruritus Research: Prisys Biotech’s IL-31-Induced NHP Model For Evaluating An...Prisys Biotech offers a translational NHP pruritus model induced by IL-31. Leveraging an advanced AI behavioral analysis system, we provide objective quantification of scratchin... -
Jul 08, 2025Respiratory Therapies: Prisys Biotech's Integrated NHP Platform For Preclinic...Explore Prisys Biotech's comprehensive preclinical platform for respiratory diseases. Discover advanced NHP models, precision pulmonary drug delivery, BALF analysis, and PFTs de... -
Jul 04, 2025NHP Pain Models: Accelerating Analgesic Drug Development At Prisys BiotechExplore Prisys Biotech's validated non-human primate (NHP) pain models for acute, chronic, and neuropathic pain. Our advanced assessment technologies, including AI-driven behavi... -
Jun 30, 2025NHP Model Platforms To Support Drug Development in Complex DiseasesPrisys Biotech, specializing in Non-Human Primate (NHP) models, has recently expanded its translational research platforms to better support drug development in dermatology, neu...
-
Jun 17, 2025Engineered Exosomes: Revolutionizing Drug Delivery For CNS Disorders – Precli...Explore the potential of engineered exosomes as advanced drug delivery vehicles for CNS diseases. Learn about their advantages, targeting strategies, and the critical role of pr... -
Jun 10, 2025Prisys Biotech’s DSA And IMRI For Hematological, Vascular, And Renal Disease ...Discover how Prisys Biotech's cutting-edge Digital Subtraction Angiography (DSA) and intraoperative MRI (iMRI) technologies, combined with expert teams, are preclinical research... -
Jun 05, 2025Cynomolgus Monkey Pain Models: Powering Translational Research For Breakthrou...Prisys Biotech offers advanced Cynomolgus monkey pain models for preclinical evaluation of breakthrough ion channel pain therapeutics. High-translational NHP models with objecti...
-
May 30, 2025Advancing Atopic Dermatitis Research: Prisys Biotech's Non-Human Primate (NHP...Explore Prisys Biotech's cutting-edge Non-Human Primate (NHP) model for Atopic Dermatitis (AD) research. Discover how our OVA-induced model and AI-driven behavioral analysis acc... -
May 27, 2025Prisys Biotech's NHP Atopic Dermatitis Model For Anti-Pruritic Drug DevelopmentDiscover how Prisys Biotech's Non-Human Primate (NHP) Atopic Dermatitis (AD) model accurately simulates human itch, aiding in the preclinical evaluation of novel anti-pruritic t...
